TruNorth Capital Management’s GSK GSK Stock Holding History

TruNorth Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Hold	4,289	–	–	0.04%	114
2026 Q1	$237K	Hold	4,289	–	–	0.05%	95
2025 Q4	$210K	Hold	4,289	–	–	0.04%	116
2025 Q3	$185K	Hold	4,289	–	–	0.04%	97
2025 Q2	$165K	Hold	4,289	–	–	0.04%	93
2025 Q1	$166K	Hold	4,289	–	–	0.04%	112
2024 Q4	$145K	Hold	4,289	–	–	0.04%	85
2024 Q3	$175K	Hold	4,289	–	–	0.05%	69
2024 Q2	$165K	Sell	4,289 -68	-2%	-$2.86K	0.05%	68
2024 Q1	$187K	Buy	+4,357	New	+$180K	0.06%	62

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

TruNorth Capital Management's GSK Position: Q2 2026 in Review

TruNorth Capital Management held its GSK (GSK) position steady in Q2 2026 at 4,289 shares worth $225K. The position accounts for 0.04% of the portfolio, ranked #114.

TruNorth Capital Management first reported a position in GSK in Q1 2024 and has held it in 10 quarters since. The position peaked at $237K in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

TruNorth Capital Management held 4,289 shares of GSK worth $225K as of Q2 2026.
TruNorth Capital Management left its GSK share count unchanged in Q2 2026.
GSK made up 0.04% of TruNorth Capital Management's portfolio in Q2 2026, its #114 holding.
TruNorth Capital Management first reported a position in GSK in Q1 2024 and has held it in 10 quarters since.
TruNorth Capital Management's GSK position peaked at $237K in Q1 2026.
1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on TruNorth Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.